Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can villagers design better cancer screening? new study puts it to the test

NCT ID NCT06640075

Knowledge-focused Sponsor: Prof. Patrick Petignat Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 19, 2026 · Updated 3 times

Summary

This study in rural Cameroon tests whether having local communities design their own cervical cancer screening strategies works better than the usual hospital-based approach. Researchers will work with women in 7 villages to create tailored plans, while 7 other villages use standard invitations. The goal is to see if community co-designed methods increase the number of women who get screened for HPV, the virus that causes cervical cancer. The study involves 800 women aged 30-49 (or 25-49 if HIV-positive) and will measure screening rates over one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
community co-produced action (participatory workshops to design local screening strategies)
What this could lead to
If successful, this approach could provide a model for increasing cervical cancer screening in underserved rural areas, potentially saving lives through earlier detection.
What could go wrong
This is an early-stage implementation study, not a treatment trial. Success depends on community engagement and may not be generalizable to other settings. The study measures screening uptake, not cancer outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2024

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 49 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 30-49 years old (25-49 years old if HIV-positive) * Residency in one of the 14 rural health areas of Mifi health district * Ability to give signed informed consent Exclusion Criteria: * known cervical cancer * symptoms compatible with cervical cancer * previous hysterectomy * terminal disease other than cervical cancer * cervical cancer screening test in the last 5 years (3 years if HIV-positive) * pregnancy at the time of screening * lack of discernment capacity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer screening

Contacts and locations

Locations

  • Bafoussam Regional Hospital

    Bafoussam, Mifi, 00237, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.